iSMART Developments Ltd has entered into a collaborative agreement with L'Oréal Groupe to co-develop and produce a new line of wearable light therapy devices. The partnership will result in an LED Face Mask and a complementary Eye Mask.
The collaboration leverages the British company’s technical proficiency in medical-grade phototherapy with the global beauty corporation’s scientific research capabilities and market reach. The co-developed light therapy devices will employ two distinct wavelengths — red for surface-level collagen production and near-infrared for deeper tissue circulation. In doing so, these innovations will work to address multiple common skincare concerns simultaneously, such as loss of firmness and under-eye puffiness, with a non-invasive method that can seamlessly fit into one's daily routines.
Co-Developed Light Therapy Devices
iSMART Developments Will Collaborate with L'Oréal
Trend Themes
-
Wearable Light Therapy — The development of wearable light therapy devices presents an opportunity to merge convenience with advanced skincare, creating accessible beauty solutions for everyday use.
-
Dual-wavelength Skincare — Utilizing dual-wavelength technology in skincare enables simultaneous targeting of multiple skin concerns, enhancing product efficacy and user satisfaction.
-
Non-invasive Skincare Innovations — Non-invasive skincare methods such as LED masks democratize advanced treatment options, making professional-grade care attainable in at-home settings.
Industry Implications
-
Beauty Tech — The convergence of technology and beauty via light therapy devices showcases the potential for tech-driven advancements to revolutionize skincare.
-
Home Healthcare — Integration of medical-grade technology into home-use devices expands the home healthcare market, allowing consumers to access professional treatments without visiting a clinic.
-
Wearable Technology — Wearable technology in the form of skincare devices is poised to redefine consumer expectations by offering personalized and on-the-go solutions.